Accendra Health, Inc.
ACH
$1.12
$0.021.82%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 613.23M | 627.78M | 708.97M | 697.26M | 681.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 613.23M | 627.78M | 708.97M | 697.26M | 681.92M |
| Cost of Revenue | 349.83M | 349.75M | 385.71M | 375.07M | 357.32M |
| Gross Profit | 263.41M | 278.03M | 323.26M | 322.20M | 324.60M |
| SG&A Expenses | 243.56M | 255.23M | 273.20M | 265.84M | 267.85M |
| Depreciation & Amortization | 29.23M | 29.23M | 29.23M | -- | 7.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 622.62M | 634.21M | 688.13M | 640.91M | 632.69M |
| Operating Income | -9.38M | -6.43M | 20.83M | 56.36M | 49.23M |
| Income Before Tax | -87.63M | -16.25M | -7.97M | -3.64M | -84.95M |
| Income Tax Expenses | 1.44M | -9.78M | 1.47M | 1.97M | -1.13M |
| Earnings from Continuing Operations | -89.07M | -6.47M | -9.44M | -5.61M | -83.82M |
| Earnings from Discontinued Operations | -- | -- | -46.88M | -144.67M | -785.24M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.07M | -6.47M | -56.33M | -150.28M | -869.06M |
| EBIT | -9.38M | -6.43M | 20.83M | 56.36M | 49.23M |
| EBITDA | 56.32M | 55.32M | 50.71M | 120.46M | 92.22M |
| EPS Basic | -1.16 | -0.08 | -0.73 | -1.94 | -11.30 |
| Normalized Basic EPS | -0.36 | -0.33 | -0.05 | 0.21 | 0.03 |
| EPS Diluted | -1.16 | -0.08 | -0.74 | -1.94 | -11.30 |
| Normalized Diluted EPS | -0.36 | -0.33 | -0.05 | 0.21 | 0.03 |
| Average Basic Shares Outstanding | 76.70M | 76.43M | 76.70M | 77.29M | 76.94M |
| Average Diluted Shares Outstanding | 76.70M | 76.43M | 76.70M | 77.29M | 76.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |